Health Medical Treatments
Menu
Home
About
Privacy
Disclaimer
Sitemap
Contact
Home
The Medical News
Nanomedicine-based strategy enhances anti-PD1 therapy to eradicate PTEN-negative GBM
Nanomedicine-based strategy enhances anti-PD1 therapy to eradicate PTEN-negative GBM
August 08, 2020
A nanomedicine-based strategy for chemo-immunotherapy (CIT) of glioblastoma (GBM), which has the worst prognosis among brain tumors, was successfully developed.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
Newer Post
Older Post
Related Post
0 Response to "Nanomedicine-based strategy enhances anti-PD1 therapy to eradicate PTEN-negative GBM"
Post a Comment
Subscribe to:
Post Comments (Atom)
Related
0 Response to "Nanomedicine-based strategy enhances anti-PD1 therapy to eradicate PTEN-negative GBM"
Post a Comment